Twist Bioscience Corporation (TWST) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.68B |
| Enterprise Value | 1.64B |
| P/E Ratio | -84.99 |
| PEG Ratio | 1.3 |
| Price/Sales Ratio | 27.21 |
| Price/Book Ratio | 26.41 |
| Enterprise/Revenue | 27.15 |
| Enterprise/EBITDA | -108.78 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.32 |
| Operating Margin | -0.32 |
| Return On Assets | -0.2 |
| Return On Equity | -0.3 |
| Revenue | 376.57M |
| Revenue/Share | 6.92 |
| Gross Profit | 191M |
| EBITDA | -52.1M |
| Net Income | -77.67M |
| Diluted EPS | -1.3 |
| Total Cash | 166.84M |
| Total Cash/Share | 2.67 |
| Total Debt | 93.59M |
| Total Debt/Equity | 0.21 |
| Current Ratio | 2.67 |
| Book Value Per Share | 7.14 |
| 52-Week Change | 514.96 |
| 52-Week High | 200.31 |
| 52-Week Low | 23.3 |
| Moving Average 50 Days | 133.79 |
| Moving Average 200 Days | 76.27 |
| Average Volume | 1.8M |
| Shares Outstanding | 62.27M |
| % Held by Institutions | 124.73 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |